Last update 01 Nov 2024
Mundipharma Deutschland GmbH & Co. KG
Last update 01 Nov 2024
Overview
Tags
Infectious Diseases
Other Diseases
Synthetic peptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Targin® for Treatment of Parkinson's disease associated severe pain - Efficacy and tolerability in real life - TIPAS
Evaluation of the effectiveness of disease management programs (DMP)Asthma and COPD - a multicenter epidemiological cross-sectional studyGerman DMP asthma (GERDA) / German COPD DMP (GERNOD) - FLT9506
An exploratory, randomised, parallel-group, open-label, multicentre study to assess the post-operative management of moderate to severe pain in patients who underwent laparoscopic cholecystectomy, receiving oxycodone hydrochloride i.v. within 12 - 24 hours after surgery at first and then oxycodone / naloxone prolonged release tablets compared to patients receiving piritramide infusions. -
100 Clinical Results associated with Mundipharma Deutschland GmbH & Co. KG
Login to view more data
Login to view more data
01 Mar 2020Pneumologie
Wirksamkeit von Disease-Management-Programmen für Asthma und COPD? Ergebnisse einer Querschnittstudie
Article
Author: Kanniess, F. ; Oepen, P. ; Hedrich, R. ; Krockenberger, K. ; Ziegler, A. ; Hessler, N. ; Langer-Brauburger, B. ; Olbrich, D.
01 Jan 2019DMW - Deutsche Medizinische WochenschriftQ4 · MEDICINE
Wirksamkeit von Disease-Management-Programmen für Asthma und COPD? Ergebnisse einer Querschnittstudie
Q4 · MEDICINE
Article
Author: Krockenberger, Katja ; Olbrich, Denise ; Hedrich, Rahel ; Hessler, Nicole ; Langer-Brauburger, Birgit ; Kanniess, Frank ; Oepen, Petra ; Ziegler, Andreas
01 Jan 2019DMW - Deutsche Medizinische WochenschriftQ4 · MEDICINE
Wirksamkeit von Disease-Management-Programmen für Asthma und COPD? Ergebnisse einer Querschnittstudie
Q4 · MEDICINE
Article
Author: Krockenberger, Katja ; Olbrich, Denise ; Hedrich, Rahel ; Hessler, Nicole ; Kanniess, Frank ; Langer-Brauburger, Birgit ; Oepen, Petra ; Ziegler, Andreas
100 Deals associated with Mundipharma Deutschland GmbH & Co. KG
Login to view more data
100 Translational Medicine associated with Mundipharma Deutschland GmbH & Co. KG
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 25 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free